Robert Burkhardt

• Achieved rank of 10 out of 48 in 2025 performance metrics.
• Received 2025 Spark Plug Award for exceptional contributions at NSM.
• Honored with District Team Leader Award for leadership excellence in 2025.
• Acknowledged by VP of Sales for highest NRX growth in 2025.
• Recognized by VP of Sales for surpassing all branded competitors in 2025.
• Ranked 7th as top 10 Klarity C conversion winner in Q1 2025.
• Earned recognition from ASM for doubling TRX growth performance in 2024.

Managed marketing and sales of colorectal cancer screening tests to physicians in Brooklyn, NY.

• Achieved 26.5% market share growth in March 2022, earning March Madness Award.
• Recognized in Q3 2023 for exemplary performance at 122% of quota.
• Secured team recognition as one of 12 representatives exceeding 100% in Q3 2022 at 112.89%.
• Received Excel Recognition for teamwork during March Madness results in April 2022.
• Achieved Cologuard 100% Club status for outstanding performance in 2021.
• Earned SPIFF for excellence in managing shipments and returns, enhancing operational success in 2021.
• Served as Northeast Compliance Team Champion for New York City/South Region.

Launched tanezumab for osteoarthritis, though FDA ultimately denied approval.

Managed marketing and sales of diverse product portfolio in Brooklyn, NY.

• Drove awareness and adoption among primary care physicians, neurologists, and cardiologists.
• Achieved 25% sales growth for Cologuard in second semester of 2021, enhancing territory performance.
• Received ACE Award for excellence in purpose blueprint initiatives in August 2021.
• Honored with ACE Award for implementation of customer-focused selling approach in October 2020.
• Recognized for commitment to Pfizer's core competencies and collaborative teamwork.
• Led compliance initiatives in Long Island district, ensuring adherence to regulations and best practices.

Managed marketing and sales of glaucoma portfolios to ophthalmologists and optometrists across New York territories.

• Achieved goal attainment of 107.20%, ranking #18 out of 72 participants.
• Won "Take What’s Yours" contest in April 2019 with 182% goal attainment.
• Secured "Mind the Gap" contest win in February 2019, maintaining over 100% in Q1 despite market competition.
• Led district culture initiatives by attending monthly national meetings focused on company culture.
• Served as QTQ committee member to enhance sales call effectiveness and maximize results.
• Participated as a direct-to-patient beta program representative, recognized for first five successful launches.
• Promoted collaboration and engagement through active contributions to team-oriented projects.

Directed marketing and sales strategies for eye and ear product portfolios targeting ophthalmologists, optometrists, otolaryngologists, allergists, pediatricians, and primary care physicians.

• Achieved recognition as winner of 'Take What's Yours' in April 2019 for Travatan Z & Azopt.
• Secured first place in 'Mind the Gap' contest in February 2019 with Travatan Z & Azopt.
• Won 'Time is Now' conversion contest for top Pazeo MS growth in May 2017.
• Ranked second nationally for AOR in 2015 sales year.
• Promoted to field sales trainer in 2015 due to outstanding performance.
• Received Moxeza Alchemist Award for top market share growth in 2015.
• Ciprodex Alchemist Award for top market share growth in 2015
• Honored with highest Pataday market share increase award of +10.6% in 2014.
• Achieving outstanding Pataday results award winner +102.6% 2014
• Pataday conversion contest award winner 2010
• Top Pataday performance award winner 2008
• Top Ciprodex award winner 2008
• Promoted to Senior Sales Representative 2007
• Most improved representation 2025

• Manage NY territories, marketing and selling Antibiotic portfolios (Avelox and Cipro XR PO and IV) to physicians and hospital pharmacies - Bayer Contract
• Exceeded goals for all 12 months of the Bayer contract (with both PO and IV) Chairman's Circle Award-most IV units sold
• Engaged P&T committee members to secure product utilization commitments, enhancing market adoption.
• Managed NY territories, marketed and sold Dermatology portfolios (Tazorac cream and gel) to Dermatologists and Pediatricians, driving brand presence.
• Managed NY territories, marketed and sold eye care portfolios (Ocuflox and Alocril) to Allergists, Ophthalmologists, and Pediatricians, expanding customer reach.